ATE431749T1 - Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff - Google Patents

Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff

Info

Publication number
ATE431749T1
ATE431749T1 AT03709792T AT03709792T ATE431749T1 AT E431749 T1 ATE431749 T1 AT E431749T1 AT 03709792 T AT03709792 T AT 03709792T AT 03709792 T AT03709792 T AT 03709792T AT E431749 T1 ATE431749 T1 AT E431749T1
Authority
AT
Austria
Prior art keywords
drug
cyclofructan
carrier
composition containing
topical composition
Prior art date
Application number
AT03709792T
Other languages
English (en)
Inventor
Gyoergy Lajos Kis
Christian Schoch
Dieter Lohmann
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229019A external-priority patent/GB0229019D0/en
Priority claimed from GB0230033A external-priority patent/GB0230033D0/en
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE431749T1 publication Critical patent/ATE431749T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03709792T 2002-03-18 2003-03-17 Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff ATE431749T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02006085 2002-03-18
GB0229019A GB0229019D0 (en) 2002-12-12 2002-12-12 Organic compounds
GB0230033A GB0230033D0 (en) 2002-12-23 2002-12-23 Organic compounds
PCT/EP2003/002760 WO2003077952A1 (en) 2002-03-18 2003-03-17 Topical composition comprising a cyclofructan, a carrier and a drug

Publications (1)

Publication Number Publication Date
ATE431749T1 true ATE431749T1 (de) 2009-06-15

Family

ID=28045916

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03709792T ATE431749T1 (de) 2002-03-18 2003-03-17 Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff

Country Status (12)

Country Link
US (2) US20060216328A1 (de)
EP (1) EP1487498B1 (de)
JP (1) JP4523287B2 (de)
CN (1) CN1313155C (de)
AT (1) ATE431749T1 (de)
AU (1) AU2003214133A1 (de)
BR (1) BR0308486A (de)
CA (1) CA2479351C (de)
DE (1) DE60327693D1 (de)
ES (1) ES2326471T3 (de)
PT (1) PT1487498E (de)
WO (1) WO2003077952A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8529927B2 (en) 2004-04-30 2013-09-10 Allergan, Inc. Alpha-2 agonist polymeric drug delivery systems
EP1787643A1 (de) * 2004-09-09 2007-05-23 Jimenez Bayardo, Arturo Implantat und mikrokugeln zur dauerhaften abgabe von medikamenten zur ophthalmischen anwendung und herstellungsverfahren dafür
US7931909B2 (en) * 2005-05-10 2011-04-26 Allergan, Inc. Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
CA2850858A1 (en) 2005-09-16 2007-04-05 Allergan, Inc. Compositions and methods for the intraocular transport of therapeutic agents
EP2471507B1 (de) * 2006-09-29 2017-03-01 Johnson & Johnson Vision Care, Inc. Ophthalmische Vorrichtungen zur Behandlung von Augenallergien
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
JP5394645B2 (ja) * 2008-03-11 2014-01-22 公益財団法人野口研究所 糖結合型スピロクラウンエーテル誘導体
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
AU2009246520B2 (en) 2008-05-12 2012-04-19 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095404B2 (en) 2008-05-12 2015-08-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
EP2437684B1 (de) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Wirkstofffreisetzung im vorderen augensegment
CN102741258B (zh) * 2009-06-17 2015-09-30 德州大学体系董事会 作为分离剂的环果聚糖的组成物及方法
DK2498783T3 (en) 2009-11-09 2018-12-10 Allergan Inc COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
JP5989780B2 (ja) 2011-09-14 2016-09-07 フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． 眼挿入装置および方法
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
RU2652063C2 (ru) 2012-10-26 2018-04-24 Форсайт Вижн5, Инк. Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
EP2956096A1 (de) 2013-02-15 2015-12-23 Allergan, Inc. Implantat mit langzeit-wirkstofffreisetzung
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
CN106074361B (zh) * 2016-07-14 2018-10-19 何伟 一种抗眼内炎症植入剂及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1491272A (en) * 1975-09-10 1977-11-09 Lingner & Fischer Gmbh Polymer adhesive compositions containing gelling agents
JPH05310805A (ja) * 1992-05-06 1993-11-22 Mitsubishi Kasei Corp アシル化環状イヌロオリゴ糖およびその製造法
JPH06141879A (ja) * 1992-11-05 1994-05-24 Mitsubishi Kasei Corp 環状イヌロオリゴ糖の精製方法
JPH06141856A (ja) * 1992-11-05 1994-05-24 Mitsubishi Kasei Corp 環状イヌロオリゴ糖及び環状イヌロオリゴ糖生成酵素の製造方法
JPH06298807A (ja) * 1993-02-19 1994-10-25 Mitsubishi Kasei Corp 新規な環状イヌロオリゴ糖誘導体
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
JPH0753347A (ja) * 1993-08-19 1995-02-28 Mitsubishi Chem Corp 皮膚化粧料
JPH07274990A (ja) * 1994-04-15 1995-10-24 Mitsubishi Kasei Eng Co 環状イヌロオリゴ糖の精製方法
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
US5980551A (en) * 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
US5972363A (en) * 1997-04-11 1999-10-26 Rohm And Haas Company Use of an encapsulated bioactive composition
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
CA2390952C (en) * 2001-07-02 2006-07-11 Rohm And Haas Company Compositions and process for retaining active ingredients comprising networked structured polymers
GB0315745D0 (en) * 2003-07-04 2003-08-13 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
DE60327693D1 (de) 2009-07-02
JP2005523299A (ja) 2005-08-04
EP1487498B1 (de) 2009-05-20
AU2003214133A1 (en) 2003-09-29
BR0308486A (pt) 2005-01-18
US20060216328A1 (en) 2006-09-28
CN1313155C (zh) 2007-05-02
ES2326471T3 (es) 2009-10-13
US20100160437A1 (en) 2010-06-24
CA2479351A1 (en) 2003-09-25
CA2479351C (en) 2012-05-15
PT1487498E (pt) 2009-08-19
CN1642578A (zh) 2005-07-20
WO2003077952A1 (en) 2003-09-25
JP4523287B2 (ja) 2010-08-11
EP1487498A1 (de) 2004-12-22

Similar Documents

Publication Publication Date Title
ATE431749T1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
DK1406633T3 (da) Forbedret lægemiddeltilførsel i transdermale systemer
DE602004004399D1 (de) Grün gefärbte,topische pharmazeutische zusammensetzung auf der basis von metronidazol
ATE445386T1 (de) Polymerische parfümpartikel
DE69928938D1 (de) Neues cyclosporin mit verbesserter wirkung
DK1545662T3 (da) Lægemiddelindgivelsessystem
ATE427763T1 (de) Ballonkatheter
TW200736293A (en) Conjugated polymers, the preparation and use thereof
AU2003241469A1 (en) Personal care articles with fragrance delivery system
MXPA06002349A (es) Derivados de aminopropanol.
MXPA05012929A (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
SI1553942T1 (sl) Farmacevtski sestavek kot kombinacija tenatoprazola in proti-vnetnega agensa
NO20043646L (no) Osmotisk leveringssystem
TW200641091A (en) Organometallic complexes
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
AU2003272260A8 (en) Verifiable absorption drug delivery form based on cyclodextrins
PL376130A1 (en) Controlled releases system containing temozolomide
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
HRP20070291T3 (hr) Farmaceutski sastav koji sadrži kompleks cink-hijaluronata za liječenje multiple skleroze
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
TW200631589A (en) Varnish composition based on a solvent of plant origin
IS7538A (is) Prógestagena skammta einingar.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1487498

Country of ref document: EP